News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Appelhans Dannielle
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Appelhans Dannielle (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 25,000 options to buy
@ $4.83, valued at
$120.8k
|
|
| 02/27/2023 |
4
| Appelhans Dannielle (CEO and President) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Sold 10,385 shares
@ $0.1274, valued at
$1.3k
|
|
| 02/01/2023 |
4
| Appelhans Dannielle (CEO and President) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Sold 3,878 shares
@ $0.25, valued at
$969.5
Exercised 7,500 restricted stock units
@ $0 |
|
| 07/19/2022 |
4
| Appelhans Dannielle (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 38,400 options to buy
@ $7.18, valued at
$275.7k
|
|
| 02/01/2022 |
4
| Appelhans Dannielle (COO) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 125,000 options to buy
@ $6.75, valued at
$843.8k
Granted 30,000 restricted stock units
@ $0 |
|
| 09/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|